Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
capsids
Biotech
Capsida pauses phase 1 gene therapy trial after child dies
AbbVie, CRISPR Therapeutics and Eli Lilly have all struck deals with Capsida.
Nick Paul Taylor
Sep 11, 2025 7:30am
Novartis ignites new stage of Voyager pact with $15M capsid deal
Sep 5, 2024 9:45am
Novartis ready to head for deep space with Voyager
Mar 6, 2023 7:00am
Neurocrine blows fresh wind in Voyager's sails with $175M payday
Jan 9, 2023 9:30am
Lilly pays $55M to join AbbVie on AAV specialist's partner list
Jan 4, 2023 7:45am
Pfizer pulls trigger on Voyager gene therapy capsid deal
Oct 4, 2022 9:46am